Archives
Finwire intervju
December 20, 2023 9:00 amKallelse till extra bolagsstämma i Redwood Pharma AB
December 19, 2023 8:30 am2023-12-19 8:30 Aktieägarna i Redwood Pharma AB, org.nr. 556885-1280, kallas härmed till extra bolagsstämma fredagen den 19 januari 2024 kl.... View Article
Redwood Pharma to participate in the JP Morgan Healthcare Conference
December 19, 2023 8:00 amStockholm, December 19, 2023. Redwood Pharma AB (publ) announces today that the company will participate in JP Morgan’s annual Healthcare... View Article
Redwood Pharma deltar i JP Morgan Healthcare Conference
December 19, 2023 8:00 amStockholm, 19 december 2023. Redwood Pharma AB (publ) meddelar idag att bolaget kommer att delta på JP Morgans årliga Healthcare-konferens i... View Article
Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)
November 30, 2023 8:30 amRedwood Pharma AB (publ) today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank... View Article
Redwood Pharma AB (publ) byter Certified Adviser till Carnegie Investment Bank AB (publ)
November 30, 2023 8:30 amRedwood Pharma AB (publ) meddelar idag att man byter Certified Adviser från Erik Penser Bank AB till Carnegie Investment Bank... View Article
Redwood Pharma AB (publ) Delårsrapport januari–september 2023
November 23, 2023 8:30 amNASDAQ FIRST NORTH GROWTH MARKET: REDW.ST, redwoodpharma.se Perioden 1 januari – 30 september 2023 Perioden 1 juli – 30 september... View Article
Delårsrapport januari–september 2023
November 23, 2023 8:30 amRedwood Pharma to participate in the NLS Days partner conference in Copenhagen
November 22, 2023 8:30 amStockholm, November 22, 2023. Redwood Pharma AB (publ) announces today that the company will participate in Nordic Life Science Days,... View Article